165 related articles for article (PubMed ID: 22199406)
1. Design, synthesis, and biological evaluation of estrone-derived hedgehog signaling inhibitors.
Winkler JD; Isaacs AK; Xiang C; Baubet V; Dahmane N
Tetrahedron; 2011 Dec; 67(52):10261-10266. PubMed ID: 22199406
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of inhibitors of Hedgehog signaling based on the alkaloid cyclopamine.
Winkler JD; Isaacs A; Holderbaum L; Tatard V; Dahmane N
Org Lett; 2009 Jul; 11(13):2824-7. PubMed ID: 19552464
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective synthesis of F-ring saturated estrone-derived inhibitors of Hedgehog signaling based on cyclopamine.
Zhang Z; Baubet V; Ventocilla C; Xiang C; Dahmane N; Winkler JD
Org Lett; 2011 Sep; 13(18):4786-9. PubMed ID: 21842835
[TBL] [Abstract][Full Text] [Related]
4. Studies directed toward the elucidation of the pharmacophore of steroid-based Sonic Hedgehog signaling inhibitors.
Isaacs AK; Xiang C; Baubet V; Dahmane N; Winkler JD
Org Lett; 2011 Oct; 13(19):5140-3. PubMed ID: 21905689
[TBL] [Abstract][Full Text] [Related]
5. Cyclopamine is a novel Hedgehog signaling inhibitor with significant anti-proliferative, anti-invasive and anti-estrogenic potency in human breast cancer cells.
Che J; Zhang FZ; Zhao CQ; Hu XD; Fan SJ
Oncol Lett; 2013 Apr; 5(4):1417-1421. PubMed ID: 23599805
[TBL] [Abstract][Full Text] [Related]
6. Cyclopamine, a naturally occurring alkaloid, and its analogues may find wide applications in cancer therapy.
Ma H; Li HQ; Zhang X
Curr Top Med Chem; 2013; 13(17):2208-15. PubMed ID: 23978132
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer.
Mukherjee S; Frolova N; Sadlonova A; Novak Z; Steg A; Page GP; Welch DR; Lobo-Ruppert SM; Ruppert JM; Johnson MR; Frost AR
Cancer Biol Ther; 2006 Jun; 5(6):674-83. PubMed ID: 16855373
[TBL] [Abstract][Full Text] [Related]
8. Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer.
Kumar SK; Roy I; Anchoori RK; Fazli S; Maitra A; Beachy PA; Khan SR
Bioorg Med Chem; 2008 Mar; 16(6):2764-8. PubMed ID: 18249125
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of SANT-2 and analogues as inhibitors of the hedgehog signaling pathway.
Büttner A; Seifert K; Cottin T; Sarli V; Tzagkaroulaki L; Scholz S; Giannis A
Bioorg Med Chem; 2009 Jul; 17(14):4943-54. PubMed ID: 19541490
[TBL] [Abstract][Full Text] [Related]
10. Ligand-based 3D pharmacophore modeling, virtual screening, and molecular dynamic simulation of potential smoothened inhibitors.
Mohebbi A
J Mol Model; 2023 Apr; 29(5):143. PubMed ID: 37062794
[TBL] [Abstract][Full Text] [Related]
11. Cyclopamine functions as a suppressor of benign prostatic hyperplasia by inhibiting epithelial and stromal cell proliferation via suppression of the Hedgehog signaling pathway.
Yuan YF; Zhu WX; Liu T; He JQ; Zhou Q; Zhou X; Zhang X; Yang J
Int J Mol Med; 2020 Jul; 46(1):311-319. PubMed ID: 32319534
[TBL] [Abstract][Full Text] [Related]
12. Integrated QSAR study for inhibitors of Hedgehog Signal Pathway against multiple cell lines:a collaborative filtering method.
Gao J; Che D; Zheng VW; Zhu R; Liu Q
BMC Bioinformatics; 2012 Jul; 13():186. PubMed ID: 22849868
[TBL] [Abstract][Full Text] [Related]
13. Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells.
Shafaee Z; Schmidt H; Du W; Posner M; Weichselbaum R
Cancer Chemother Pharmacol; 2006 Dec; 58(6):765-70. PubMed ID: 16552573
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells.
Mimeault M; Moore E; Moniaux N; Hénichart JP; Depreux P; Lin MF; Batra SK
Int J Cancer; 2006 Feb; 118(4):1022-31. PubMed ID: 16108016
[TBL] [Abstract][Full Text] [Related]
15. The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitors.
Xin M; Wen J; Tang F; Tu C; Shen H; Zhao X
Bioorg Med Chem Lett; 2013 Dec; 23(24):6777-83. PubMed ID: 24176396
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the anti-adipogenic Hedgehog signaling pathway by cyclopamine does not trigger adipocyte differentiation.
Cousin W; Dani C; Peraldi P
Biochem Biophys Res Commun; 2006 Oct; 349(2):799-803. PubMed ID: 16949046
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).
Tremblay MR; Lescarbeau A; Grogan MJ; Tan E; Lin G; Austad BC; Yu LC; Behnke ML; Nair SJ; Hagel M; White K; Conley J; Manna JD; Alvarez-Diez TM; Hoyt J; Woodward CN; Sydor JR; Pink M; MacDougall J; Campbell MJ; Cushing J; Ferguson J; Curtis MS; McGovern K; Read MA; Palombella VJ; Adams J; Castro AC
J Med Chem; 2009 Jul; 52(14):4400-18. PubMed ID: 19522463
[TBL] [Abstract][Full Text] [Related]
18. An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.
Feldmann G; Fendrich V; McGovern K; Bedja D; Bisht S; Alvarez H; Koorstra JB; Habbe N; Karikari C; Mullendore M; Gabrielson KL; Sharma R; Matsui W; Maitra A
Mol Cancer Ther; 2008 Sep; 7(9):2725-35. PubMed ID: 18790753
[TBL] [Abstract][Full Text] [Related]
19. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells.
Mimeault M; Johansson SL; Vankatraman G; Moore E; Henichart JP; Depreux P; Lin MF; Batra SK
Mol Cancer Ther; 2007 Mar; 6(3):967-78. PubMed ID: 17363490
[TBL] [Abstract][Full Text] [Related]
20. Design and biological evaluation of phenyl imidazole analogs as hedgehog signaling pathway inhibitors.
Sun C; Zhang Y; Wang H; Yin Z; Wu L; Huang Y; Zhang W; Wang Y; Hu Q
Chem Biol Drug Des; 2021 Mar; 97(3):546-552. PubMed ID: 32946174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]